Critical Care – Medxy AI

$Neurofilament Light Chain Reveals Rapid Neuroaxonal Injury in New-Onset Refractory Status Epilepticus$

Neurofilament Light Chain Reveals Rapid Neuroaxonal Injury in New-Onset Refractory Status Epilepticus

By MedXY 04/30/2026

In a multinational cross-sectional study, serum and CSF neurofilament light chain—unlike S100B—tracked severe acute brain injury in cryptogenic NORSE, rose rapidly over the first 3 weeks, and predicted poor short-term outcome, supporting urgent neuroprotective treatment.

Cardiology Critical Care news

Circulatory Support Escalation in Cardiogenic Shock: Outcomes and Predictors of Success

By MedXY 04/28/2026

A multi-center study reveals that circulatory support escalation in cardiogenic shock is associated with higher mortality and complications, but certain patient factors can predict successful outcomes.

Critical Care Infectious Diseases news

Biomarker Signatures in Sepsis: Linking Host Response to Clinical Outcomes

By MedXY 04/28/2026

A prospective cohort study identifies biomarker signatures for host resistance, disease tolerance, and damage in sepsis, revealing associations with mortality and sepsis subtypes.

Cardiology Critical Care news

Early Resistance Training and Verticalization During ECMO: A Safe Path to Improved Functional Outcomes

By MedXY 04/28/2026

A structured exercise program combining mobility therapy and resistance training in ECMO patients proved feasible and safe, with longer session times correlating with better functional performance.

Critical Care Infectious Diseases news

Cultural Diversity in ICU: A Protective Factor Against Sepsis Mortality

By MedXY 04/24/2026

A multicenter study reveals that culturally and linguistically diverse patients with sepsis had lower in-hospital mortality and shorter ICU stays compared to non-CaLD patients, challenging prior assumptions about healthcare disparities.

Critical Care Infectious Diseases news

Antifungal Therapy Slashes Mortality in COVID-19-Associated Pulmonary Aspergillosis: European Data Confirms

By MedXY 04/23/2026

A multicenter European cohort study demonstrates that antifungal treatment significantly reduces 60-day mortality in COVID-19-associated pulmonary aspergillosis (CAPA), particularly in immunocompromised patients. Key findings underscore the urgency of CAPA screening and targeted therapy in critical care settings.

Critical Care Emergency Medicine news

Higher EMS Clinician Trauma Volume Linked to Lower Early Mortality in Trauma Patients

By MedXY 04/23/2026

A study finds that increased annual trauma patient volume per EMS clinician is associated with significantly reduced 6-hour and in-hospital mortality rates, highlighting the importance of experience in prehospital trauma care.

Critical Care Nephrology news

Low-Calorie, Low-Protein Feeding in Shock: No Harm to Kidneys, NUTRIREA-3 Analysis Confirms

By MedXY 04/21/2026

Early low-calorie and low-protein nutrition in critically ill patients with shock does not worsen renal outcomes compared to standard feeding, per NUTRIREA-3 post hoc analysis.

Critical Care Neurology news

Language Barriers and Delirium Detection: Study Reveals Critical Disparities in ICU Care for Spanish-Speaking Patients

By MedXY 04/21/2026

A new study highlights significant disparities in delirium detection for Spanish-speaking ICU patients, with usual-care methods missing 72% of cases. Caregiver-administered tools improved detection by 47%, offering a potential solution to language-based inequities in critical care.

Cardiology Critical Care news

Transfer Before Support: Why Cardiogenic Shock Patients Referred from Regional Centers Face Higher Device-Related Complications

By MedXY 04/15/2026

A large observational study reveals that cardiogenic shock patients receiving temporary mechanical circulatory support at regional referral centers before transfer to hub centers experience significantly higher device-related adverse events and mortality compared to those receiving initial support at hub centers, though this difference may be explained by greater illness severity.

Anesthesiology Critical Care news

Remimazolam Besylate Matches Propofol for Short-Term ICU Sedation: The SHOSREB Trial

By MedXY 04/13/2026

The SHOSREB trial demonstrates that remimazolam besylate is non-inferior to propofol for short-term light sedation in mechanically ventilated ICU patients, with both agents achieving 97.5% successful sedation rates and comparable time within target RASS scores.

Critical Care news Respiratory

Mortality Trends in Mechanically Ventilated ARDS: 20 Years of Paradox Revealed

By MedXY 04/02/2026

A landmark 20-year analysis of over 200,000 mechanically ventilated ARDS patients reveals a striking paradox—mortality declined during the ICD-9 era but increased after ICD-10 adoption, challenging assumptions about ARDS outcomes and highlighting the complex interplay between coding practices, patient complexity, and clinical care.

Critical Care Internal Medicine news

Mind the Gap: Why Point-of-Care and Central Lab Electrolytes Are Not Interchangeable in the ICU

By MedXY 03/29/2026

A prospective study highlights significant discrepancies between point-of-care and central laboratory sodium and potassium measurements in the ICU, revealing a 10.48 mmol/L limit of agreement for sodium and a widespread lack of physician awareness regarding these analytical biases.

Critical Care Emergency Medicine news

Rethinking Shock Management: From Standardized Protocols to Personalized Precision Medicine

By MedXY 03/19/2026

Expert consensus highlights a shift in shock treatment, emphasizing that standardized protocols must give way to personalized, physiology-driven bedside care to prevent iatrogenic injury and improve survival.

Clinical Updates Critical Care news

Electrolyte Monitoring in the ICU: Bridging the Gap Between Point-of-Care and Central Laboratory Discrepancies

By MedXY 03/17/2026

This review analyzes the analytical biases between direct and indirect potentiometry for sodium and potassium measurement in critical care, highlighting significant clinical classification discrepancies and a widespread lack of physician awareness regarding methodological differences.

Critical Care news Psychiatry

Antipsychotic Exposure in the ICU: A Double-Edged Sword for Catatonia Risk?

By MedXY 03/14/2026

A prospective cohort study demonstrates that antipsychotic use in critically ill patients is significantly associated with fewer catatonia-free days, suggesting that dopamine blockade may be a primary driver of catatonic syndromes in intensive care settings.

Cardiology Critical Care news

Etiology, Management, and Outcomes of Society for Cardiovascular Angiography and Interventions Stage B Cardiogenic Shock

By MedXY 03/10/2026

This clinical analysis of 500 patients identifies heart failure and arrhythmias as the primary causes of SCAI Stage B shock. Key findings highlight acute kidney injury and diuretic resistance as significant predictors of clinical deterioration and the need for escalation of care.

Critical Care Infectious Diseases news

Daily Chlorhexidine Bathing in the ICU: Results from the CLEAN-IT Multicentre Trial

By MedXY 03/02/2026

A large-scale trial in Brazilian ICUs found that daily chlorhexidine bathing did not lower overall nosocomial infection rates but significantly reduced multi-drug resistant pathogen isolation and the use of high-priority reserve antibiotics without increasing mortality.

Critical Care news Pediatrics

Plasma GFAP and NfL Levels Predict Acute Brain Injury and Poor Outcomes in Pediatric ECMO

By MedXY 03/02/2026

This multi-center study demonstrates that serial monitoring of plasma GFAP and NfL biomarkers can detect acute brain injury in pediatric ECMO patients before imaging diagnosis, significantly correlating with long-term survival and functional outcomes.

Critical Care news Pediatrics

Plasma GFAP and NfL as Real-Time Predictors of Brain Injury and Long-Term Disability in Pediatric ECMO

By MedXY 03/02/2026

A prospective study demonstrates that rising levels of plasma GFAP and NfL precede neuroimaging-confirmed brain injury in children on ECMO. These biomarkers are also strongly associated with mortality and long-term functional impairment, offering a new window for neuroprotective monitoring.